Company Profile

Kepler Diagnostics Inc
Profile last edited on: 1/12/23      CAGE: 7TFT5      UEI: JCB4S8XCCFJ7

Business Identifier: Bodily fluid collection solutions
Year Founded
2016
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4685 Runway Street Suite K
Simi Valley, CA 93063
   (805) 791-2094
   info@keplerdx.com
   www.keplerdx.com
Location: Single
Congr. District: 25
County: Ventura

Public Profile

Kepler Diagnostics Inc develops devices and solutions for specimen collection. The firm's primary product, Samplla X, is an at home blood self-collection device that dries the blood and separates plasma from blood cells while keeping the sample integrity of liquid blood. This offers advantages over traditional, Dried Blood Spot (DBC) cards, providing high sensitivity and stability for antibodies, enzymes and low concentration analyses. In addition to blood, the technology has applications for urine, plasma, and other bodily fluids and does not require cold-chain logistics with materials such as foam, dry ice, overnight shipping, and specialized sample logistics. This technology facilitates testing, making previously difficult to stabilize specimens easily testable.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $256,000
Project Title: A system for collection, transportation and accurate analysis of RNA virus specimens

Key People / Management

  Avinoam Dukler -- Co-Founder, President & CEO

  Stuart Ringold -- Head of Operations & Business Development

  Arti Tiwari -- Head of R&D

Company News

There are no news available.